Russian elite using experimental coronavirus vaccine since April
Kremlin-linked tycoons and political figures given early access to potential Covid-19 jab
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
Russia’s political and business elite have reportedly been given early access to a coronavirus vaccine that has been in use since April.
Sources familiar with the country’s bid to develop the first Covid inoculation told Bloomberg that top executives, billionaire tycoons and government officials have been getting the shots, developed by the state-run Gamaleya Institute in Moscow.
The vaccine project is being financed by the state-run Russian Direct Investment Fund and supported by the Defence Ministry. Insiders say the jab is “a so-called viral vector vaccine”, combining “human adenovirus - a common cold virus” with “the spike protein of SARS CoV-2” to create an immune response, according to the news agency.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The vaccine is expected to be ready for distribution in Russia by September, with initial trials involving military personnel completed last week, The Times says.
The Gamaleya Institute “hasn’t published results for the study, which involved about 40 people, but has begun the next stage of testing with a larger group”, adds Bloomberg.
Dozens of “well-connected Russians” have reportedly volunteered for doses of the experimental vaccine, but “none would allow their names to be published”.
However, executives at Rusal, the aluminium giant founded by oligarch Oleg Deripaska, are understood to be among those receiving the vaccine. Whether Deripaska, a close ally of Vladimir Putin, has used the drug personally is unclear.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Such testing is legal, but is said to have been “kept under wraps to avoid a crush of potential participants”.
Kremlin spokesperson Dmitry Peskov has claimed not to know the names of anyone receiving the institute’s vaccine. Asked if President Putin has had the jab, Peskov told reporters that “it probably wouldn’t be a good idea to use an uncertified vaccine on the head of state”.
Although the effectiveness of the new vaccine has yet to be proven, the jab is based on proven vaccines for other diseases and as such should be “safe”, according to Sergei Netesov, a former executive at Vector, a state-run virology centre in Siberia that is also working on an inoculation.
But “those who take it do so at their own risk”, he added.
Putin has made “finding a vaccine a top priority”, though “some Western experts remain skeptical that Russia has the expertise to produce its own vaccine by September”, reports Fortune.
Joe Evans is the world news editor at TheWeek.co.uk. He joined the team in 2019 and held roles including deputy news editor and acting news editor before moving into his current position in early 2021. He is a regular panellist on The Week Unwrapped podcast, discussing politics and foreign affairs.
Before joining The Week, he worked as a freelance journalist covering the UK and Ireland for German newspapers and magazines. A series of features on Brexit and the Irish border got him nominated for the Hostwriter Prize in 2019. Prior to settling down in London, he lived and worked in Cambodia, where he ran communications for a non-governmental organisation and worked as a journalist covering Southeast Asia. He has a master’s degree in journalism from City, University of London, and before that studied English Literature at the University of Manchester.
-
How Democrats are turning DOJ lemons into partisan lemonadeTODAY’S BIG QUESTION As the Trump administration continues to try — and fail — at indicting its political enemies, Democratic lawmakers have begun seizing the moment for themselves
-
ICE’s new targets post-Minnesota retreatIn the Spotlight Several cities are reportedly on ICE’s list for immigration crackdowns
-
‘Those rights don’t exist to protect criminals’Instant Opinion Opinion, comment and editorials of the day
-
What happens now that the US-Russia nuclear treaty is expiring?TODAY’S BIG QUESTION Weapons experts worry that the end of the New START treaty marks the beginning of a 21st-century atomic arms race
-
Epstein files topple law CEO, roil UK governmentSpeed Read Peter Mandelson, Britain’s former ambassador to the US, is caught up in the scandal
-
Iran and US prepare to meet after skirmishesSpeed Read The incident comes amid heightened tensions in the Middle East
-
Israel retrieves final hostage’s body from GazaSpeed Read The 24-year-old police officer was killed during the initial Hamas attack
-
China’s Xi targets top general in growing purgeSpeed Read Zhang Youxia is being investigated over ‘grave violations’ of the law
-
Ukraine, US and Russia: do rare trilateral talks mean peace is possible?Rush to meet signals potential agreement but scepticism of Russian motives remain
-
Panama and Canada are negotiating over a crucial copper mineIn the Spotlight Panama is set to make a final decision on the mine this summer
-
Why Greenland’s natural resources are nearly impossible to mineThe Explainer The country’s natural landscape makes the task extremely difficult